These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20940159)

  • 21. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone.
    Chisholm SA; Unemo M; Quaye N; Johansson E; Cole MJ; Ison CA; Van de Laar MJ
    Euro Surveill; 2013 Jan; 18(3):. PubMed ID: 23351652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe.
    Chisholm SA; Quaye N; Cole MJ; Fredlund H; Hoffmann S; Jensen JS; van de Laar MJ; Unemo M; Ison CA
    J Antimicrob Chemother; 2011 Mar; 66(3):592-5. PubMed ID: 21172790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
    Jabeen K; Khan E; Hasan R
    Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
    Tapsall JW
    Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
    Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
    J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.
    Ison CA; Alexander S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):867-76. PubMed ID: 21973299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?
    Unemo M; Brooks B; Cole M; Ross JD; White JA; Patel R;
    Int J STD AIDS; 2013 Jun; 24(6):423-6. PubMed ID: 23970742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae.
    Cole MJ; Chisholm SA; Hoffmann S; Stary A; Lowndes CM; Ison CA;
    Sex Transm Infect; 2010 Nov; 86(6):427-32. PubMed ID: 20940154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy.
    Carannante A; Vacca P; Ghisetti V; Latino MA; Cusini M; Matteelli A; Vocale C; Prignano G; Leli C; Ober P; Antonetti R; Poletti F; Stefanelli P
    Microb Drug Resist; 2017 Mar; 23(2):247-252. PubMed ID: 27347854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emergence of Neisseria gonorrhoeae with decreased susceptibility to Azithromycin in Kansas City, Missouri, 1999 to 2000.
    McLean CA; Wang SA; Hoff GL; Dennis LY; Trees DL; Knapp JS; Markowitz LE; Levine WC
    Sex Transm Dis; 2004 Feb; 31(2):73-8. PubMed ID: 14743069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
    Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
    Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
    Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
    Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.
    Martin IM; Hoffmann S; Ison CA;
    J Antimicrob Chemother; 2006 Sep; 58(3):587-93. PubMed ID: 16816397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.
    Grad YH; Kirkcaldy RD; Trees D; Dordel J; Harris SR; Goldstein E; Weinstock H; Parkhill J; Hanage WP; Bentley S; Lipsitch M
    Lancet Infect Dis; 2014 Mar; 14(3):220-6. PubMed ID: 24462211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic susceptibility of Neisseria gonorrhoeae in Arkhangelsk, Russia.
    Vorobieva V; Firsova N; Ababkova T; Leniv I; Haldorsen BC; Unemo M; Skogen V
    Sex Transm Infect; 2007 Apr; 83(2):133-5. PubMed ID: 16971401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence and spread of drug resistant Neisseria gonorrhoeae.
    Deguchi T; Nakane K; Yasuda M; Maeda S
    J Urol; 2010 Sep; 184(3):851-8; quiz 1235. PubMed ID: 20643433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance of Neisseria gonorrhoeae in Jakarta, Indonesia: a cross-sectional study.
    Indriatmi W; Prayogo RL; Nilasari H; Suseno LS
    Sex Health; 2020 Feb; 17(1):9-14. PubMed ID: 31837714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
    Castor D; Prabhakar P; Furlonge C; Rao A; Brown A; Camara B; Weiss H; Jolly PE
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):987-95. PubMed ID: 11785665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.